efgartigimod clinical trials

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

This study looks at the safety of a new medicine called efgartigimod for people with myasthenia gravis (gMG). Researchers are observing patients as they take the medicine in their everyday lives to understand its effects.